Olfactory dysfunction and amyloid-positivity in Parkinson’s disease—longitudinal analysis of cognitive decline and cerebrospinal fluid markers
Saved in:
| Main Authors: | Victoria Larsson, Sara Hall, Kaj Blennow, Oskar Hansson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12370119/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01) -
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2016-08-01) -
The genetic regulation of protein expression in cerebrospinal fluid
by: Oskar Hansson, et al.
Published: (2022-12-01) -
Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy.
by: Ulrika Andersson-Hall, et al.
Published: (2021-01-01) -
Relationship between cerebrospinal fluid circulation markers, brain degeneration, and cognitive impairment in cerebral amyloid angiopathy
by: Li Zhao, et al.
Published: (2025-04-01)